Anglo-French Drugs & Industries – Growfast Direct

Healthcare & Pharmaceuticals

Unlisted

Current Price

₹ 1078

52W Low

₹2262

▲ 5.2% this month

- 3.2% this month

52W High

₹2666

Market Cap

₹255.83 Cr

▲ 5.2% this month

- 3.2% this month

Price Performance

Historical indicative price trend

Key Financials

Revenue (TTM)

₹90.32 Cr

Net Profit

₹22.85

EBITDA

₹ 28.1 Cr

EPS

₹-3.5

ROE

16.78%

ROCE

15.95

Debt / Equity

0.16

Book Value

₹1305.22

Face Value

10

About

Anglo-French Drugs & Industries

Founded

1923

Headquarters

Bengaluru, Karnataka, India

Employees

NA

Listed (IPO)

Unlisted

Anglo-French Drugs & Industries is an Indian pharmaceutical manufacturing company engaged in the production and marketing of pharmaceutical formulations and healthcare products. The company primarily focuses on branded generic medicines across therapeutic segments such as antibiotics, vitamins, gastrointestinal treatments, and other prescription drugs.

Read More

Founded in 1923, the company has over a century of operating history in the Indian pharmaceutical sector and operates its manufacturing facility in Bengaluru, Karnataka. Anglo-French Drugs distributes its products mainly in the domestic market through pharmaceutical distributors and healthcare professionals. The company operates in the formulations segment, generating revenue primarily from the sale of finished dosage pharmaceutical products. While smaller in scale compared to large pharmaceutical companies, it maintains a diversified product portfolio and continues to operate in India’s highly competitive generic drug market.

Shareholders

Name

2026

Promoters

64.84%

Life Insurance Corporation of India (LIC)

7.04%

Others

28.12%

Promoter and Management

Promoter and Management

Designation

Mr. Abhay Kanoria

Chairman & Managing Director

Mr. Nirbhay Abhay Kanoria

CFO

Particulars

FY22

FY23

FY24

FY25

FY26

Total Revenue

166.14

110.1

99.84

117.99

129.38

Total Revenue YoY Growth (%)

7.33

-33.73

-9.32

18.18

9.65

EBITDA

9.41

257.49

-7.29

12.98

-28.1

EBITDA Margin (%)

5.69

251.19

-7.66

14.79

31.11

EBIT

6.51

254.15

-10.44

9.71

24.82

EBIT Margin (%)

3.94

251.19

-10.97

11.06

27.48

PBT

2.24

251.08

-12.29

7.93

22.8

PBT Margin (%)

1.35

244.93

-12.91

9.03

25.24

PAT

1.88

190.94

-12.34

7.22

-22.85

Revenue from Operations

165.32

102.51

95.2

87.79

90.32

YoY Growth (%)

-74.17

9137.5

-106.7

-162.63

225.81

EPS (Diluted ₹)

16

1478

-99

62

202

Particulars

FY22

FY23

FY24

FY25

FY26

Total Non-Current Assets

19.17

18.62

25.08

31.67

27.15

Total Current Assets

77.93

254.26

194.52

160.73

178.52

Total Assets

97.1

272.86

219.6

192.4

205.67

Total Non-Current Liabilities

30.21

25.81

13.03

11.25

8.11

Total Current Liabilities

47.97

38.21

35.67

56.35

50.08

Total Liabilities

78

64

35.67

67.6

58.19

Total Equity

18.92

208.84

170.9

124.8

147.49

Total Liabilities and Equity

97.1

272.86

219.6

192.4

205.67

Particulars

FY22

FY23

FY24

FY25

FY26

Cash & Cash Equivalents (Closing)

0.5

2.83

0.09

0.22

39

Operating Activities (A)

13.73

184.69

-0.06

-1.91

-2.21

Investing Activities (B)

-9.06

-170.4

41.36

44.71

-0.28

Financing Activities (C)

-4.81

-11.7

-44.06

-46.49

2.67

Net (Decrease) / Increase (A+B+C)

-0.14

2.59

-2.76

0.13

0.18

Particulars

FY22

FY23

FY24

FY25

FY26

Current Ratio (x)

1.62

6.65

5.45

2.85

3.56

Cashflow Ratio (x)

3.56

4.83

0

0.03

-0.04

EBIT Margin (%)

3.94

247.93

-10.97

11.06

27.48

Net Profit Margin (%)

1.14

186.26

-12.96

8.22

25.3

ROA (%)

1.96

103.22

-5.01

-5.01

11.48

ROE (%)

10.75

167.67

-6.5

4.88

16.78

ROCE (%)

13.25

108.31

-5.68

7.14

15.95

Operating Profit Margin (%)

3.94

247.93

-10.97

11.06

27.48

PBT Margin (%)

1.35

244.93

-12.91

9.03

25.24

EBITDA Margin (%)

5.69

251.19

-7.66

14.79

31.11

Debt to Equity (x)

1.86

0.12

0.05

0.15

0.16

Get More Information

Fill in your details and our team will reach out shortly.

Quick Snapshot

ISIN

INE218H01017

CIN

₹10

Industry

Financial Services

Lot Size

50 Shares

Dipository:

NSDL & CDSL

PAN No.

AAICK4821A

Registration Date

26/05/2026

Why Choose GrowFast

Your trusted partner in unlisted shares investment discovery

Verified & Transparent Data

Every company listing on Grow Fast undergoes manual verification. We display only accurate, up-to-date information — no inflated numbers, no misleading claims.

Curated for Serious Explorers

We handpick companies that meet our quality bar. Our team monitors each listing regularly so you're always looking at credible, relevant opportunities.

Zero Clutter. Pure Information

No push to buy. No noise. Grow Fast is built purely to inform — so you can research, compare, and decide at your own pace with zero pressure.

Ready to Explore Unlisted Opportunities?

Join thousands of informed investors who trust GrowFast for their unlisted
shares research

Blogs & News

How Are Unlisted Shares Valued? Understanding Price Discovery in the Private Market

How Are Unlisted Shares Valued? Understanding Price Discovery in the Private Market Investing in unlisted companies has gained significant traction as investors look beyond traditional

Pre-IPO Investing Explained: Benefits, Risks, and How to Get Started

Pre-IPO Investing Explained: Benefits, Risks, and How to Get Started Pre-IPO investing gives investors the opportunity to buy shares of a company before it is

Listed vs Unlisted Shares: Key Differences Every Investor Should Know

Listed vs Unlisted Shares: Key Differences Every Investor Should Know Investing in the stock market offers a wide range of opportunities, and one of the

How to Buy Unlisted Shares in India: A Complete Beginner’s Guide (2026)

How to Buy Unlisted Shares in India: A Complete Beginner’s Guide (2026) Investing in unlisted shares has become an increasingly popular way for investors to